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SUMMARY 20 
The current state of myiasis vaccine technologies are reviewed mainly in the primary research 21 
genera of Lucilia and Hypoderma.  The importance of myiasis flies as primary causes of 22 
morbidity and mortality in agricultural species and man has not diminished despite the 23 
existence of good control strategies. However, the development of vaccines against myiasis 24 
infections has been relatively quiescent for more than ten years despite the rapid development 25 
of genomic and proteomic analysis and of skills in data interpretation. The value of vaccine 26 
research in an era of chemical primacy is analysed. In fact, recent findings of drug resistance 27 
and the impact of animal welfare concerns should mean a renewed interest in alternative 28 
controls. The reasons that this has not been true to date are explored and new possibilities 29 
discussed.   30 
 31 
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INTRODUCTION 36 
Myiasis infections are caused by the larvae (maggots) of a range of blowfly species with 37 
various consequences for the host. Generally the species can be divided into three groups 38 
based on their pathology including those causing skin infections to various depths (cutaneous 39 
myiasis) those infecting body orifices and the gastrointestinal tract (bot flies) and those which 40 
infect and often migrate subcutaneously (the warbles).  The bots and warbles are members of 41 
the Oestridae while the skin infecting flies are largely Calliphoridae though a few 42 
Sarcophagidae are also active. A large range of species engage in parasitism though only a 43 
few are obligate parasites.  Genetic analysis suggests that obligate parasitism has evolved on a 44 
number of occasions among the Calliphoridae while the Oestridae are a monophyletic group 45 
of obligate parasites 1. The most important species with respect to human and domestic 46 
animal health include Calliphoridae such as Lucilia spp - sheep blowflies; the screwworms - 47 
Cochliomyia and Chrysomya spp and the Sarcophagid, Wohlfahrtia magnifica; while the 48 
Oestridae include Oestrus ovis – nasal flies; Gasterophilus spp– horse bot flies; Dermatobia 49 
hominus - human warble fly and Hypoderma spp – warble flies 2.  A range of other flies can 50 
infect the skin or body orifices of debilitated or moribund animals and humans or cause 51 
secondary infections but many of these are opportunistic carrion flies with less economic but 52 
significant individual effect.   53 
The two major infections that have been the subjects of most research efforts for novel 54 
controls and a better understanding of pathology and immune reactivities, are the sheep 55 
blowflies, Lucilia cuprina and L. sericata and the warble flies, Hypoderma bovis and H. 56 
lineatum.  These species mainly infect sheep (Lucilia) and cattle (Hypoderma) respectively 57 
and cause significant pathology and mortality in the case of Lucilia 3, while Hypoderma 58 
causes morbidity and losses including damage to hides 4. Other species can cause significant 59 
disease in various hosts in specific areas including the screwworms especially in South 60 
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America; though the success of the sterile insect release in the USA and Central America has 61 
limited the range of Cochliomyia 5. The old world screwworm is Chrysomya bezziana and 62 
some vaccine work has been undertaken, mainly as a result of this species’ threat of invasion 63 
of the Australian mainland from the Indonesian archipelago leading to vaccine funding in the 64 
early 2000s. Much more widespread but similarly under utilized in research efforts are the 65 
common bot flies such as Oestrus and Gasterophilus and a range of other species that effect 66 
livestock and wild animals worldwide. Work on these species is limited but has included 67 
some analysis of pathology and basic vaccine responses 6,7,8.  Finally work on Dermatobia has 68 
been very limited but promising while the wonderfully named Wohlfahrtia magnifica, which 69 
may be expanding its range in Europe, Africa and parts of Asia 9 and causes significant losses 70 
in a wide range of livestock including camels 10 is relatively untouched.  71 
Control of all these infections has been and still is, reliant mainly on chemical insecticides 72 
though management strategies are also important for the sheep blowfly to allow control in 73 
extensive grazing situations 11. The reliance on insecticides and the inexorable rise of drug 74 
resistance to most classes of insecticide, has driven the search for alternative control 75 
mechanisms including the use of genetic, biological and immunological technologies 12.  The 76 
other more recent driver particularly for sheep blowfly control has been animal welfare 77 
concerns around the mulesing operation and to a lesser extent tail docking 13, 14.  Mulesing is 78 
the surgical removal of the wool bearing skin on either side of the vulva which regrows as 79 
bare skin and is thus much less subject to urine and faecal staining 15.  This can reduce the 80 
chance of blowfly strike around the tail by over 60% 15 but it is undertaken without 81 
anaesthetic and has thus been targeted by PETA (People for the Ethical Treatment of 82 
Animals) and others as a major animal welfare concern16. As a result the wool industry in 83 
Australia is keen to phase out the use of this procedure 16. 84 
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A recent and perhaps surprising direction for pathological and immunological analyses 85 
especially of the blowfly Lucilia sericata is the use of the maggots for wound debridement 86 
and infection control, particularly in Europe 17.  This work has been driven by the appearance 87 
of multiple drug resistant strains of various bacteria and the need to treat a range of wounds 88 
that are refractory to the more usual treatments 18.  The maggots are placed in the wound 89 
either directly or more usually contained in fine net bags and their secretions clean out the 90 
eschar and reduce the bacterial load to encourage healing 19.  The success of this approach has 91 
resulted in a more detailed analysis of the larval secretions and an analysis of the site of 92 
application on the host to better understand the cleaning and healing response.  There is also 93 
an effort to isolate particular enzyme and anti-bacterial activities to enable the development of 94 
new treatments 17.  95 
Analysis of immune and inflammatory responses against Hypoderma and the sheep blowfly 96 
began in the 1970s 20, 21.  However, a concentrated effort to develop vaccines was coincident 97 
with the development of recombinant technology and the ability to carefully dissect host 98 
pathological and immune responses to maggots and their components.  This technology led to 99 
work on both natural antigens – exposed to the host during infection and hidden antigens – 100 
only exposed to the host via vaccination but accessible to host immune attack. As with most 101 
complex metazoan parasites the extracts of larvae initially tested for vaccine effects were not 102 
particularly effective 22 though the work on Hypoderma was always more rewarding than 103 
similar studies on the sheep blowfly 23. 104 
To explain this difference and the quite different results that are explored later in this review a 105 
short examination of life cycles and host reactions is necessary.  Sheep blowflies lay their 106 
eggs communally on stained or wet wool allowing the larvae to establish on the skin 24,25, they 107 
then degrade the epidermis 24 which causes an exudative wound that spreads as the larvae 108 
grow until it can cover a significant fraction of the animal’s skin.  This wound results in water 109 
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loss as the larvae inhibit coagulation and release a range of active enzymes and other toxins 110 
26,17. Depending on the size and health of the host around 1000 larvae (approx. five female 111 
egg masses) can have significant negative effects on sheep health 27.  Female flies are 112 
attracted to ovipositing females and recently laid eggs, as a result, one egg mass can soon be 113 
joined by number of others causing rapid morbidity and mortality in a significant percentage 114 
of a flock 2. To date there have been no studies that show any consistent resistance to repeated 115 
infections 28 though there are certainly animals that are resistant to infection and it is possible 116 
to breed resistant animals by direct selection 29. 117 
The warble flies show quite a different infection strategy and resultant host response.  These 118 
flies lay their eggs singly or in groups of up to twenty on the skin surface usually on host hairs 119 
30.  The larvae hatch and penetrate the skin, then migrate into the deep tissues of the body 120 
where they ‘rest’ and grow for a period of several months before migrating to their site of 121 
predilection usually the back of the bovid host 31.  Here the host forms a warble or lump with 122 
a central hole to the surface through which they respire 31. On reaching larval maturity after 123 
about a month, they leave the host through the hole and drop to the ground to pupate.  The 124 
host usually shows significant resistance to the larvae after the first season of exposure and 125 
this is further enhanced after subsequent exposures. Thus fewer warbles are seen on older 126 
animals 32,33.  127 
A number of other infections have been analysed for host immune activities and these will be 128 
discussed in the article but the clear majority of work has involved the species described 129 
above.  It is also interesting that despite the quite different outcomes in terms of the 130 
application of these immune studies to each of these infections, the current controls for both 131 
forms of myiasis are still reliant on the technologies developed in the 1970s. 132 
 133 
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SHEEP BLOWFLY INFECTIONS 134 
Overview 135 
A study of the immune response to blowfly infections in sheep spans over 35 years of 136 
research in which a range of observations have been reported in the literature 12,34,35. Despite 137 
these observations it is clear that we still know comparatively little about the detailed immune 138 
responses induced by larvae upon primary and subsequent infections of the host. Furthermore 139 
we know even less about the changes that take place in the larvae themselves in response to 140 
their environmental stimuli. Clearly it is only through a greater understanding of this intricate 141 
relationship that we can attempt to better manage this important ectoparasite especially if the 142 
aim is to develop an effective prophylactic vaccine or other immune based intervention 143 
strategies.  144 
This section of the review will focus on the literature associated with describing the immune 145 
response in sheep to the sheep blowfly. Specific areas addressed will include the humoral and 146 
inflammatory response of the host to the larvae and the implications for the development of 147 
immunity, immunosuppression, host response to vaccination and impediments to vaccine 148 
development. Commentary will also be made on the development of new technologies and 149 
approaches to identifying possible vaccine targets.  150 
The humoral immune responses to infection was first reported back in the early 1980’s 36 and 151 
several groups have further investigated the nature of both the systemic and local humoral 152 
response during infection 28,37-41. These humoral responses have been shown to be directed 153 
against E/S products of the larvae 42,43 and the salivary antigens 37 following natural infection. 154 
While the response has been characterized by the production of IgG 36,41 with subsequent 155 
analysis identifying a number of isotypes including IgG1, IgG2, IgA and IgM 44 and IgE 45 156 
with the primary isotype being identified as IgG1 42.  157 
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Along with the humoral responses a series of studies also investigated the cellular immune 158 
responses occurring during infection with the larvae 38,46. The responses following both 159 
primary and secondary infections are characterized by massive cellular infiltrations within 48 160 
h of wound initiation, with the majority of cells having the CD45 phenotype and neutrophils 161 
comprising the major cell type at the skin surface.  Other phenotypes reported in the skin of 162 
flystruck sheep included CD1+ Langerhans’ cells, CD4+ T helper, γδ-TCR+ cells and T19+ 163 
(CD4−, CD8−) T cells 46-48. Changes noted in local cytokine responses in the skin and 164 
draining lymph nodes 47,49 included increases as detected via RT-PCR, in expression of IL-1α, 165 
Il-1β, IL-8 and in IL-6 via northern analysis 50. For a more detailed review of the cellular 166 
events occurring following blowfly larval infections refer to the review by Elkington and 167 
Mahony 34.  168 
Based on the descriptions of the cellular responses it is clear that a complicated series of 169 
inflammatory events occur during flystrike infections. While the findings might not be too 170 
surprising given the nature of the acute insult to the skin by the larvae, an important question 171 
is whether this knowledge provides some insight firstly into explaining the lack of a 172 
protective acquired immune response to the larvae and/or whether it might provide important 173 
clues into the development of a vaccine against the larvae. 174 
 175 
Inflammation versus immunity 176 
Previously the composition of the cells that infiltrate the site of infection was briefly 177 
described as comprising neutrophils, eosinophils, macrophages and lymphocytes of which 178 
CD4 and γδ-TCR+ make up a large proportion of the infiltrating lymphocytes. Associated 179 
with this knowledge is the finding that sheep are able to mount a variety of hypersensitivity 180 
responses post challenge to larval antigens with some of these responses notably immediate-181 
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type and Arthus responses bearing some correlation with partial acquired resistance to the 182 
larvae 38. An important point to note is that while it has been possible to demonstrate partial 183 
protection to the larvae in an experimental setting following repeated larval challenge, it is 184 
still not clear what key components of the immune system are contributing to this transient 185 
immune response. Furthermore, the apparent lack of protective immunity to the larvae in the 186 
field provides strong evidence that whatever immune responses are induced by the larvae they 187 
are either irrelevant or not of sufficient magnitude to control the larvae during natural 188 
challenge in an outbred flock. The reference to outbred flocks is interesting based on the 189 
significant amount of research conducted on the Trangie line of sheep that had been selected 190 
for resistance/susceptibility to fleece-rot and flystrike since 1974 51. One key finding from 191 
these sheep is that under natural flystrike conditions in one year old sheep it was reported that 192 
19% of sheep classed as susceptible suffered body strike compared to only 1% of the resistant 193 
flock 51. Further analysis of the hypersensitivity response to larval excretory/secretory 194 
proteins reported a more sustained hypersensitivity response in rams selected for innate 195 
resistance (R) compared to the susceptible (S) rams 53. It was also suggested that this 196 
difference in hypersensitivity response implied a genetic difference between flocks which 197 
could possibly be used for selection of resistant animals. These R versus S sheep were also 198 
monitored for a range of molecules present in exudates collected at varying times from 199 
flystrike wounds. Significant differences were detected in the exudate compositions for 200 
Complement C3, a fragment of IgG, α1-antitrypsin and for a range of unidentified peptides 201 
and it was suggested at the time that the more rapid exudation of acute-phase and serum 202 
proteins at infection sites on R sheep may allow the inhibition of the establishment of fleece 203 
rot bacteria or L. cuprina larvae under natural challenge 41. The Trangie flock may therefore 204 
harbor important information on the innate response to challenge infection with the larvae in 205 
the field. How to translate these responses or assess their importance to outbred animals is a 206 
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difficult question to answer, however given that a variety of responses had been documented 207 
some of which correlated with protection and coupled with the finding that sheep can show 208 
resistance to natural challenge drove research into the direction of exploring vaccination as an 209 
alternative to chemical control of this parasite.  210 
 211 
Vaccine responses 212 
Over the years a number of vaccination strategies have been investigated using a wide range 213 
of larval antigens, reviewed by Elkington and Mahony 34. The basic premise for vaccination is 214 
to induce an immune response in the host that would inhibit larval growth and ultimately 215 
survival. Ideally such an approach would result in a reduced dependence on insecticides 216 
providing protection over critical periods during the season when flies are most prevalent. A 217 
number of reports identified the production of serum antibodies to various larval antigens post 218 
vaccination and subsequent anti-larval growth effects in vitro 54-61 however these results 219 
generally did not translate into significant protection following implants with first stage larvae 220 
in vivo. The reasons for this apparent inability to translate in vitro effects to the in vivo 221 
situation were suggested to include insufficient antibody titres present in the skin, the 222 
degradation of IgG at the wound site and the time required to reach peak antibody titres in the 223 
sera 40,62,63. In contrast to the reports where vaccination failed to illicit a protective response in 224 
vivo, was the study by Bowles et al 64 in which vaccination with four partially-purified 225 
antigens induced an 86% (Trial 1) and a 67% (Trial 2) reduction in the incidence of strike 226 
compared to unvaccinated controls. In addition, larvae recovered from vaccinated animals 227 
(Trial 1) were up to 85% smaller than their control counterparts. It was also noted that 228 
antibody titres from the protected sheep failed to correlate with protection which is not 229 
inconsistent with previous efforts to correlate protection with antibody titres. However, what 230 
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was very interesting was the presence of cellular foci described at the site of challenge in 231 
protected animals, which consisted of CD1+ Langerhans’ cells, CD4+ T helper and γδ-TCR+ 232 
cells, and these foci may have provided an early immune response upon larval challenge in 233 
primed animals that significantly affected the ability of the larvae to successfully establish64. 234 
While delayed-type hypersensitivity responses (DTH) were also measured post larval 235 
implantation this parameter did not correlate with protection.  236 
 237 
Inhibitors of immune control - immunosuppression 238 
Producing an effective vaccine against the sheep blowfly presents numerous significant 239 
challenges as attested by the results obtained thus far for vaccination attempts. There are 240 
many factors to consider including the choice of antigen(s), the type of immune response to 241 
be elicited (humoral vs cellular or both), the route of administration, (subcutaneous, 242 
intramuscular or possibly intradermal), the choice of adjuvant or immunomodulators and the 243 
number and timing of immunisations.  These factors are not trivial issues to be researched and 244 
whilst some progress has been made a significant body of research remains incomplete if a 245 
blowfly vaccine is to be effective. Another important point to consider when seeking to 246 
produce an effective vaccine is the ability of the larvae to influence the immune response of 247 
the host. Such interactions are common place in the parasite world 65. With respect to the 248 
sheep blowfly the ability of the larvae to degrade host immunoglobulin 62 is one clear 249 
example whereby the larvae are capable of avoiding the host humoral immune response. In 250 
addition, excretory-secretory (E/S) products produced by the larvae have been shown to be 251 
able to directly influence the immune response at both the cellular and humoral levels 66. The 252 
results from this study demonstrated that the proliferation of ovine lymphocytes could be 253 
suppressed in vitro following exposure to the larval products but interestingly this suppression 254 
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could be reversed. Elkington et al.67 reported that a 56 kDa protein from E/S material was 255 
shown to be capable of significantly inhibiting lymphocyte proliferation and it was proposed 256 
that this particular protein may have an immunomodulatory role during blowfly infections. 257 
These types of responses are not surprising given the lack of protective immunity 258 
demonstrated against this parasite in the field and what is known from other parasites as they 259 
have evolved to avoid host immune responses 68. What will be challenging from a vaccine 260 
perspective is to identify the key immunomodulatory molecules produced by the larvae as 261 
presumably these too would be useful vaccine candidates.  262 
 263 
New approaches to control. 264 
As mentioned previously, an understanding of the interaction between the sheep host and the 265 
larvae is critical to the development of an effective vaccine strategy. Previous research on this 266 
interaction has been performed largely in the absence of genomic data and produced a few, 267 
partial sequences of potential vaccine candidate proteins 69-71. An exception to this is the 268 
extensive work that was conducted on the peritrophins from Lucilia in which a number were 269 
cloned and sequenced 57,58,72.  The sheep genome (http://www.sheephapmap.org) and the 270 
nearly completed L. cuprina genome (5K genome project) 271 
(http://www.arthropodgenomes.org/wiki/Main_Page), combined with the power of mass 272 
spectrometry and transcriptomic data analyses, should result in the completion and 273 
characterization of these partial proteins and in the identification of additional novel potential 274 
candidate target genes for both vaccine and drug development purposes. Transcriptomic and 275 
proteomic analyses of blowfly larvae and sheep during infection, should deliver novel insights 276 
into the sheep’s immune response and result in the assembly of blowfly secretomes; a wide 277 
range of secreted proteins of different larval stages that are potential candidates for vaccine 278 
  13 
design. Furthermore, essential genes are ideal candidates for drug targeting in the blowfly and 279 
can now be inferred from the available information on the related non-parasitic fly species, 280 
Drosophila melanogaster and validated using molecular knockout techniques, such as 281 
CRISPR 73.The missing component in the delivery of these molecular techniques and vaccine 282 
development is adequate and sustained funding which has been largely unavailable from 283 
industry or other sources for over ten years, despite the mulesing controversy and the obvious 284 
importance of developing alternative therapies. 285 
 286 
Other Blowflies 287 
Vaccine research in other blowfly species has been very limited and has concentrated mainly 288 
on the screwworms which penetrate deep into their hosts after infecting through wounds or 289 
body orifices. As a result they can cause rapid mortality especially in young and stressed 290 
animals.  They are also non-selective in their host range, successfully infecting most available 291 
mammals and some birds 74. Cochliomyia hominovorax, the new world screwworm has been 292 
controlled in a large part of its previously endemic range via the release of genetically-altered 293 
‘sterile’ male flies 5. However, its persistence in South America and occasional incursion 294 
elsewhere 75 suggests that additional controls are still needed.  Chrysomya bezziana, the old 295 
world screwworm fly, is endemic in Asia and Africa 76. It has long been a major quarantine 296 
concern in Northern Australia with significant populations of the fly in the Torres Strait 77. 297 
Chrysomya bezziana 298 
In common with Lucilia, the screw-worm, Chrysomya bezziana secretes highly active 299 
products onto the host.  These consist of a mixture of enzymes and toxins that inhibit 300 
coagulation, degrade complement components, lyse cells and degrade skin matrix proteins 78. 301 
Analysis in the 1980s confirmed that skin reactions to the screwworms were similar to Lucilia 302 
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with neutrophil accumulation followed by fibrosis, eosinophilia and mast cell proliferation 303 
after the larvae had dropped off the host 79. 304 
Analysis of the protease enzymes present in the larval secretions again shows similar 305 
composition to Lucilia 78. This paper also reports unpublished vaccination trials with these 306 
proteases though without significant effect, a finding which again mimics the Lucilia data. 307 
In keeping with the Lucilia lead, the peritrophin 48 gene was isolated from Chrysomya, 308 
expressed in bacteria and compared to both the Lucilia and Drosophila homologues 80. This 309 
antigen and two other peritrophin molecules (Cb15 and Cb42) were then used in vaccine trails 310 
in sheep 41. No significant differences were found in vitro with Cb15 and Cb42 and only a 311 
small negative effect on growth occurred with Cb48. In vivo the vaccination apparently 312 
caused a small increase in larval weight over controls 41. The results suggest that these 313 
proteins are less effective as antigen targets in Chrysomya than they are in Lucilia though 314 
additional studies on adjuvants and protocols may improve such responses. However, the lack 315 
of significant effect was not conducive to further funding and the program was not extended 316 
beyond the initial trials. 317 
 318 
WARBLE INFECTIONS 319 
Overview 320 
As long as records have been kept researchers and cattlemen have noted that cattle develop 321 
resistance to cattle grub infections. This translates into fewer grubs per animal in older 322 
animals and has been reported in the literature numerous times 82-84. 323 
Confusion reigns with regard to whether the impact of immune responses mostly affects early 324 
first instars as they migrate through the internal tissues of the host 83 or whether the impact of 325 
the immune response mostly affects late second and early third instars as they reside in the 326 
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warble 84,85.  This dichotomy is of particular relevance to the commercial success of a vaccine 327 
which would ideally prevent damage to hide and sub-dermal tissues that results from 328 
formation of warbles. 329 
Cellular responses to invading first instars have been described in artificial infections and 330 
show very little change in cell types associated with primary infections 86.  The infiltration of 331 
B cells and IgG positive cells shortly after challenge infections in perivascular areas was 332 
dramatic and rapid 86. Local and systemic cytokine responses in the first few days of both 333 
primary and challenge infections have been reported by 87 who suggest that the bovine 334 
response is framed by both Th1 (increase in IFN-γ) was well as Th2 (increases in IL-4 and IL-335 
10) responses.  Similarly, inflammatory cell responses in skin of primary and challenge 336 
infections 88 showed an increase in CD4+ during the early phase of primary infections while B 337 
cells were predominant in challenge infections and the numbers increase in association with 338 
the number of previous infections.  339 
Cytokine and antibody responses have been recently characterized in naturally infested 340 
animals during the later phases of the infection by Vasquez et al 89 and Panadero et al 90.  341 
These authors suggest that in natural infections the cytokine profiles were less clear than in 342 
artificial, pulse infections 87,88 and a similar situation was observed for inflammatory cells.  343 
IL-10 was higher in challenge infections which they interpreted as allowing reduced 344 
inflammatory responses which increased the survival of migrating first instars. They noted 345 
that the inflammation regulatory cytokine IL-10 declined rapidly after larvae had exited the 346 
warbles which was consistent between primary and challenge infections, suggesting that this 347 
cytokine was important in maintaining the host granuloma from which the second and third 348 
instars derive their nutrient. 349 
 350 
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Vaccine natural antigens 351 
The earliest work on vaccines dates to the 1950’s 91 and 1960’s 92,93. These studies used whole 352 
third instar antigens and the vaccine was delivered after animals were naturally infested. 353 
Baron and Colwell 94 reported the use of native hypodermins as vaccine components with the 354 
addition of monophosphoryl lipid A as an adjuvant. Pruett 95 reported an increase in cattle 355 
grub mortality in cattle vaccinated with native HyA, but the bulk of the mortality was 356 
observed at the second and third instar stage in the host’s subdermal tissues.  This aspect was 357 
detrimental to the vaccine approach as while it had a measure of population control the 358 
immediate damage to hides and carcasses was not eliminated.  This was followed by studies 359 
reporting the production of recombinant antigens (reviewed by 95,96). 360 
Panadero et al. 85 described the immunomodulatory effect of three serine proteinases from 361 
first instars of H. lineatum, reporting that lymphocyte proliferative responses were down 362 
regulated particularly by HyA as had been previously noted by Nicolas-Gaulard et al. 97.  In 363 
addition these authors reported a down regulation of cytokine responses that was also strongly 364 
mediated by HyA.  Hypodermin C had a much less significant effect while HyB was 365 
intermediate in effect. 366 
 367 
Vaccine hidden antigens 368 
Colwell 98 reported up to 100% mortality of cattle grubs in calves immunized with soluble 369 
extracts of third instar fat body formulated with Quil A as the adjuvant.  Significant increases 370 
in mortality of migrating first instars was noted as well as increased mortality of second and 371 
third instars in vaccinated animals in comparison with untreated controls and adjuvant only 372 
treated animals. Subsequent LC – MS/MS analysis of four bands (29, 50, 60 and 80 kDa) 373 
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from SDS-PAGE separated proteins that were subjected to MASCOT database searches 374 
revealed peptides with similarities to several proteins. 375 
Interesting proteins that had protein scores of greater than 400 included the 376 
Hexamerins/arylphorins (also known as larval serum proteins), which are storage proteins of 377 
the hemocyanin family that act as amino acid pools for reconstruction associated with insect 378 
metamorphosis and in some cases support egg production 99. These proteins have also been 379 
identified by Roelfstra et al 8 in second and third instar Gasterophilus intestinalis. A 380 
Glutathione-S-transferase from a multifunctional family of enzymes that protect cells by 381 
preventing the damaging effects of oxygen and other free radicals. These are widely used in 382 
anti-parasite vaccines; e.g. Haemaphysalis longicornis and Rhipicephalus microplus 100 383 
Schistosoma mansoni 101, Psoropotes ovis 102, Necator americanus 103. Arginine kinase is a 384 
crucial enzyme that catalyzes the transfer of phosphoryl groups from ATP to arginine in 385 
arthropods and has been noted as an excellent target for drug development.  It has also been 386 
implicated as a major human allergen 104 and is found in parasitic nematodes where it has 387 
been suggested as a potential vaccine candidate 105. Phenoloxidase is a major component of 388 
the insect immune system that participates in encapsulation and wound healing through 389 
formation of melanin 106. 390 
 391 
Recombinant antigens 392 
The gene sequences for the three major proteins secreted by first instar Hypoderma spp, were 393 
first reported in the early 1990s 107, but work with recombinant versions of these enzymes 394 
predated that description.  Recombinant versions of these serine proteinases were formulated 395 
and expressed as inclusion bodies in E. coli at both the Lethbridge Research Centre and at the 396 
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USDA Kerrville laboratory.  Hypodermin A was chosen to be the primary component of the 397 
vaccine which was formulated with alhydrogel/amphigen as the adjuvant 96.   398 
 399 
Current state of potential vaccines 400 
All research into the use of recombinant hypodermins for cattle grub control effectively ended 401 
in the late 1990`s.  This was the result of difficulty obtaining patents for the production of the 402 
antigens and the advent of macrocyclic lactone endectocides.  A recent attempt to use 403 
`hidden` antigens as vaccine components while highly successful relied on the use of a 404 
cocktail of uncharacterized native antigens.  Other than what has been mentioned in the 405 
previous section there has been no further work to determine the most active components in 406 
the cocktail or to develop recombinant proteins for evaluation of their effect. 407 
 408 
Inhibitors of immune control 409 
Immunosuppression 410 
HyA has been shown to have a potent inhibitory effect 97,85 through down regulation of 411 
lymphocyte proliferation.  Hypodermin C has been reported to degrade complement 412 
component C3 108. Other cattle grub immunosuppressive effects have been noted for HyC 109. 413 
Macrocyclic lactone endectocides with their extremely high efficacy against Hypoderma 110 414 
and their ease of use have effectively spelled the end of vaccine research and development on 415 
cattle grubs. The macrocyclic lactones are so effective against cattle grubs that eradication 416 
campaigns in which ‘micro-dose’ applications at 1/10 the recommended dose have been 417 
proposed 111,112 With the appearance of drug resistance to these products in cattle gastro-418 
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intestinal nematodes 113,114 there has been a push to develop new active ingredients such as 419 
monepantel 115 and to develop combination treatments which will undoubtedly have a 420 
macrocyclic lactone as a component.  This will continue to have an effect on vaccine research 421 
against bot flies. 422 
 423 
Other bot flies 424 
Dermatobia hominis 425 
Work with Dermatobia hominus has been stimulated by its increasing incidence in travellers 426 
returning from, and its continuing importance in, South America 116-118 though identification 427 
is not always proven in travellers 119.  428 
Dermatobia hominis females capture mammophilic flies, in mid flight, depositing several 429 
eggs onto their abdomens.  These flies visit a host, often for a blood meal, and the increased 430 
temperature stimulates eggs to hatch releasing the larvae.  Larvae penetrate the host skin and 431 
begin to develop without deep tissue migration such as occurs with some other cuterebrid 432 
larvae. 433 
Studies of this fly have again analysed E/S products for protease activity with a serine 434 
protease mix again found to be dominant 120.  A notable finding is a high molecular weight 435 
metalloprotease produced by the first instar. This is suggested to be active during skin 436 
invasion though further work is required to confirm the hypothesis. Other warble flies seem to 437 
be more reliant on the serine proteases and particularly collagenolytic serine proteases for 438 
invasion, so further work would be interesting. 439 
A recent study used immunodominant antibodies to identify and isolate an antigen for a 440 
vaccine trial in cattle.  Thus whole larval somatic extracts were used to immunize cattle and 441 
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then identify an antibody in immune sera that recognised an immunodominant 50 kDa antigen 442 
121.  This was isolated from the soluble extracts of whole Dermatobia larvae, of all three 443 
instars and used to vaccinate cattle. This approach yielded a greater than 90% reduction in the 444 
number of surviving larvae after challenge. 445 
The success of the approach suggests alternative vaccine antigens to the established use of the 446 
Hypodermins in other warble flies 88 as the molecular weight of this antigen is almost twice 447 
that of these serine proteases.  Other studies in Hypoderma have indicated the presence of 448 
tissue-derived antigens at about this molecular weight 98. 449 
Oestrus ovis 450 
The final group of Oestridae with recent work reported are the nasal bots which includes 451 
Oestrus ovis and Rhinoestrus spp, parasites of sheep/goats and equines respectively. These 452 
parasitic flies are inhabitants in the upper sinus of their hosts and tend to be specific to their 453 
hosts, which include equids, artidodactyls and even a species in macropods (kangaroos)122.  454 
Oestrus ovis females forcefully expel fully developed first instars directly onto the nose of the 455 
host.  The larvae are encased in a viscous fluid that aids them staying on the host.  Shortly 456 
after deposition the larvae migrate initially into the outer nasal passages where development 457 
begins.  Later the larvae will move to the nasal sinuses and other cavities within the head.  458 
These larvae tend to be very common in their hosts infecting from 30 to 50% of flocks in 459 
most studies (reviewed in 123). The larvae produce very similar enzymes to the more invasive 460 
oestridae 124 and the major antigens recognized by the host are excretory/secretory products 461 
including salivary gland antigens 125.  However, immunisation with E/S products did not show 462 
any protective effect other than limited growth inhibition 126. Use of ‘hidden antigens’ derived 463 
from washed third instar digestive tracts had also no effect on larval survival, but reduced the 464 
size of the larvae, primarily of second instars 126. 465 
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Gasterophilus 466 
Gasterophilus spp. females deposit eggs onto the host hairs where they remain attached until 467 
they are induced to hatch by the friction and or moisture of host grooming activity.  Larvae 468 
penetrate the oral mucosa and undergo migration within the oral cavity for some days 469 
(specifics of the migration and site vary by species).  Following a brief period of development 470 
the larvae drop into the gastro-intestinal tract, find species-specific attachment sites and 471 
complete development. 472 
Despite the importance of these both flies to the horse industry worldwide there has been little 473 
effort to describe immune responses or to develop vaccines. Roelfstra et al. 8 have described 474 
horse immune responses to crude extracts of whole second and third instar G. intestinalis 475 
along with a description of some of the proteins identified by tandem mass spectroscopy. As 476 
outlined in the Hypoderma discussion several of the proteins appear similar to those described 477 
from the fatbody of Hypoderma lineatum (e.g. larval serum protein, arylphorin). 478 
 479 
CONCLUSION 480 
The issue for those concerned with the development of new controls for myiasis diseases is 481 
the continuing reliance in insecticides over the last 50 years and the lack of current research 482 
towards alternatives.  This is especially true of vaccine work where no significant funding has 483 
been available since 2000.  Although this could be argued as due to a lack of potential 484 
candidate vaccines in the case of the sheep blowflies (Lucilia) there have been good 485 
candidates for Hypoderma control for at least this period 94.  486 
Clearly the drugs currently available, which include the macrocyclic lactones and the insect 487 
growth regulators (esp. chitin synthesis inhibitors), are very effective and relatively cheap 488 
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though resistance is known in field populations of Lucilia 128,129.  Drugs have allowed virtual 489 
eradication of Hypoderma populations in most western European countries apparently 490 
without the induction of resistant strains 129. Such ready availability of cheap and effective 491 
control has inhibited research into other measures especially in the last ten years.  The only 492 
issue with this suppression is that once resistance does develop, as it has in Lucilia to almost 493 
all commercial drugs used to date 128, then there will be little if anything available other than 494 
drug combinations and a scramble to rapidly reassess past research for alternative controls. 495 
An example of the effect of the lack of funding into novel controls is the situation with 496 
mulesing and the Australian wool industry, mentioned in the introduction to this review.  497 
Complaints about the welfare and cruelty issues involved in mulesing sheep are not new and 498 
animal welfare groups have been active against the operation for many years 130. The 499 
involvement of PETA who threatened an international boycott of wool from mulesed sheep in 500 
2004 was merely the final act of a long building issue 130. The response of the industry in 501 
2004 was to fund research into a limited range of alternatives to mulesing 131, this amounted 502 
to other methods of performing the same operation and an analysis of breeding options to 503 
select plain bodied sheep 132, more recently selection for blowfly resistance has joined the list 504 
29, though both these genetic options are obviously long term.  As a result the declaration by 505 
the Australian Wool Corporation that they would stop mulesing by 2010 has not been 506 
achieved and the boycotts are extending 133. Although funding vaccine research may not have 507 
resolved the issue it should be noted that even vaccines with 60% protective effect can add 508 
significant control options in integrated management programs 134, which are the only 509 
currently available strategies for blowfly control in unmulesed sheep 11. In addition and as 510 
discussed earlier, changes in technology over the last ten years have added significantly to our 511 
ability to find and test target molecules in parasites and these technologies are rapidly 512 
advancing our understanding of a wide range of other parasite-host interactions. The same 513 
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cannot be said of myiasis infections and a reassessment of the potential for immune based 514 
control of these infections is surely in order. 515 
  516 
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